ImmunologybioRxivPreprint
A Secreted Subunit SARS-CoV-2 RBD-CpE Yeast Oral Vaccine Induces an Adaptive Immune Response in BALB/c Mice
John Donnie Ramos, Christopher Bresnahan, Taylor V. Brysgel…·Nicanor Pier Giorgio Austriaco
This study develops an oral yeast vaccine using Saccharomyces boulardii expressing SARS-CoV-2 RBD-CpE, which induces RBD-specific IgG/IgA and IFN-gamma in mice.
DOI 10.64898/2025.12.08.692901